WallStSmart

India Globalization Capital Inc (IGC) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

India Globalization Capital Inc stock (IGC) is currently trading at $0.26. India Globalization Capital Inc PS ratio (Price-to-Sales) is 23.66. Analyst consensus price target for IGC is $4.00. WallStSmart rates IGC as Sell.

  • IGC PE ratio analysis and historical PE chart
  • IGC PS ratio (Price-to-Sales) history and trend
  • IGC intrinsic value — DCF, Graham Number, EPV models
  • IGC stock price prediction 2025 2026 2027 2028 2029 2030
  • IGC fair value vs current price
  • IGC insider transactions and insider buying
  • Is IGC undervalued or overvalued?
  • India Globalization Capital Inc financial analysis — revenue, earnings, cash flow
  • IGC Piotroski F-Score and Altman Z-Score
  • IGC analyst price target and Smart Rating
IGC

India Globalization Capital Inc

NYSE MKTHEALTHCARE
$0.26
$0.01 (3.91%)
52W$0.24
$0.50
Target$4.00+1421.5%

📊 No data available

Try selecting a different time range

WallStSmart

Smart Analysis

India Globalization Capital Inc (IGC) · 7 metrics scored

Smart Score

13
out of 100
Grade: F
Avoid
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.

India Globalization Capital Inc (IGC) Key Strengths (0)

Avg Score: 0/10

Supporting Valuation Data

IGC Target Price
$4
1334% Upside

India Globalization Capital Inc (IGC) Areas to Watch (7)

Avg Score: 1.9/10
Return on EquityProfitability
-83.30%0/10

Company is destroying shareholder value

Operating MarginProfitability
-1518.00%0/10

Losing money on operations

Revenue GrowthGrowth
-53.60%0/10

Revenue declining -53.60%, a shrinking business

Price/SalesValuation
23.662/10

Very expensive at 23.7x annual revenue

Market CapQuality
$26M3/10

Micro-cap company with very limited liquidity and high volatility

Price/BookValuation
3.664/10

Premium pricing at 3.7x book value

Institutional Own.Quality
20.11%4/10

Low institutional interest, mostly retail-driven

Supporting Valuation Data

Price/Sales (TTM)
23.66
Overvalued
EV/Revenue
22.02
Overvalued

India Globalization Capital Inc (IGC) Detailed Analysis Report

Overall Assessment

This company scores 13/100 in our Smart Analysis, earning a F grade. Out of 7 metrics analyzed, 0 register as strengths (avg 0/10) while 7 fall into concern territory (avg 1.9/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

Limited fundamental strengths were identified. The bull case requires improvement in core metrics.

The Bear Case

The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Some valuation metrics including Price/Sales (23.66), Price/Book (3.66) suggest expensive pricing. Growth concerns include Revenue Growth at -53.60%, which may limit upside. Profitability pressure is visible in Return on Equity at -83.30%, Operating Margin at -1518.00%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -83.30% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -53.60% needing to reaccelerate.

Risk Considerations

Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

IGC Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

IGC's Price-to-Sales ratio of 23.66x trades at a deep discount to its historical average of 293.86x (47th percentile). The current valuation is 99% below its historical high of 2640.14x set in Sep 2007, and 1499% above its historical low of 1.48x in Apr 2009. Over the past 12 months, the PS ratio has expanded from ~20.8x, reflecting growing market expectations outpacing revenue growth.

Compare IGC with Competitors

Top BIOTECHNOLOGY stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for India Globalization Capital Inc (IGC) · HEALTHCAREBIOTECHNOLOGY

The Big Picture

India Globalization Capital Inc operates as a stable business with moderate growth and solid fundamentals. Revenue reached 1M with 54% decline year-over-year. The company is currently unprofitable, posting a 0.0% profit margin.

Key Findings

Low Leverage

Debt-to-equity ratio of 0.02 indicates a conservative balance sheet with 1M in cash.

Heavy R&D Investment

Spending 134% of revenue (1M) on R&D, reinforcing its commitment to innovation and future growth.

Revenue Decline

Revenue contracted 54% YoY. Worth determining whether this is cyclical or structural.

Negative Free Cash Flow

Free cash flow is -1M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.

What to Watch Next

Sector dynamics: monitor BIOTECHNOLOGY industry trends, competitive moves, and regulatory changes that could impact India Globalization Capital Inc.

Bottom Line

India Globalization Capital Inc offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions

Loading insider activity...

About India Globalization Capital Inc(IGC)

Exchange

NYSE MKT

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Country

USA

India Globalization Capital, Inc. buys and resells physical infrastructure commodities. The company is headquartered in Potomac, Maryland.

Visit India Globalization Capital Inc (IGC) Website
10224 FALLS ROAD, POTOMAC, MD, UNITED STATES, 20854